High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated
- 15 April 2008
- journal article
- Published by American Society of Hematology in Blood
- Vol. 111 (8), 4329-4337
- https://doi.org/10.1182/blood-2007-10-119230
Abstract
Inappropriate expression of EVI1 (ecotropic virus integration-1), in particular splice form EVI1-1D, through chromosome 3q26 lesions or other mechanisms has been implicated in the development of high-risk acute myeloid leukemia (AML). To validate the clinical relevance of EVI1-1D, as well as of the other EVI1 splice forms and the related MDS1/EVI1 (ME) gene, real-time quantitative polymerase chain reaction was performed in 534 untreated adults with de novo AML. EVI1-1D was highly expressed in 6% of cases (n = 32), whereas 7.8% were EVI1+ (n = 41) when all splice variants were taken into account. High EVI1 predicted a distinctly worse event-free survival (HR = 1.9; P = .002) and disease-free survival (HR = 2.1, P = .006) following multivariate analysis. Importantly, we distinguished a subset of EVI1+ cases that lacked expression of ME (EVI1+ME−; n = 17) from cases that were ME+ (EVI1+ME+; n = 24). The atypical EVI1+ME− expression pattern exhibited cytogenetically detectable chromosomal 3q26 breakpoints in 8 cases. Fluorescence in situ hybridization revealed 7 more EVI1+ME− cases that carried cryptic 3q26 breakpoints, which were not found in the EVI1+ME+ group. EVI1+ME− expression predicts an extremely poor prognosis distinguishable from the general EVI1+ AML patients (overall survival [OS]: P < .001 and event-free survival [EFS]: P = .002). We argue that EVI1/ME quantitative expression analysis should be implemented in the molecular diagnostic procedures of AML.Keywords
This publication has 32 references indexed in Scilit:
- EVI1 and hematopoietic disorders: History and perspectivesGene, 2006
- EVI1 is consistently expressed as principal transcript in common and rare recurrent 3q26 rearrangementsGenes, Chromosomes and Cancer, 2005
- Regulation of the expression of the oncogene EVI1 through the use of alternative mRNA 5′-endsGene, 2005
- Prognostically Useful Gene-Expression Profiles in Acute Myeloid LeukemiaNew England Journal of Medicine, 2004
- The value of fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high-risk myelodysplastic syndromes and AML in elderly patientsBlood, 2004
- Effect of Priming with Granulocyte Colony-Stimulating Factor on the Outcome of Chemotherapy for Acute Myeloid LeukemiaNew England Journal of Medicine, 2003
- Quantitative comparison of the expression of EVI1 and its presumptive antagonist, MDS1/EVI1, in patients with myeloid leukemiaGenes, Chromosomes and Cancer, 2002
- High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patientsBlood, 2002
- Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family.Proceedings of the National Academy of Sciences of the United States of America, 1996
- Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band 3q26.Proceedings of the National Academy of Sciences of the United States of America, 1992